SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
---|---|---|---|---|---|
SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
SYSMHC00023_HLA-I-p_MM15 | 15 | Human | HLA-A03:01,HLA-A68:01,HLA-B27:05,HLA-B35:03,HLA-C02:02,HLA-C04:01 | ||
SYSMHC00023_HLA-I-p_MM16 | 5 | Human | HLA-A01:01,HLA-A24:02,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | ||
SYSMHC00023_HLA-I-p_MM21 | 3 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MM_12 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MM_20 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_1 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_10 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_11 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_12 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_13 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_15 | 1 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_16 | 1 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_17 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_18 | 3 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_19 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_2 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_3 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_4 | 3 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_5 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_6 | 2 | Human | no allele | ||
SYSMHC00023_HLA-I-p_MMf_7 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MM15 | 8 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MM16 | 6 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MM20 | 1 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MM21 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_1 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_10 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_11 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_12 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_13 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_15 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_16 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_17 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_18 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_2 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_3 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_4 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_5 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_6 | 2 | Human | no allele | ||
SYSMHC00023_HLA-II-p_MMf_7 | 2 | Human | no allele | ||
SYSMHC00023_MM12-HLAp | 4 | Human | HLA-A01:01,HLA-B08:01,HLA-C07:01 | ||
SYSMHC00023_MM3-HLAp | 4 | Human | no allele | ||
SYSMHC00023_MM4-HLAp | 4 | Human | no allele | ||
SYSMHC00023_MM5-HLAp | 4 | Human | HLA-A01:01,HLA-A25:01,HLA-B08:01,HLA-B18:01 | ||
SYSMHC00023_MM8-HLAp | 4 | Human | HLA-A01:01,HLA-A03:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 |
ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
SYSMHC00023 | SYSMHC00023_MM5-HLAp | SYSMHC00023_20140305_EXQ6_MiBa_SA_MM5-HLAp-1.raw | Human | In vivo | Skin | Melanoma | Metastatic | class I | HLA-A01:01,HLA-A25:01,HLA-B08:01,HLA-B18:01 | 27869121 | native | Immunoaffinity | W6/32 | Q-Exactive HF | no-LC, Proxeon Biosystems, Thermo | no | DDA | HCD | 2-30% ACN | 90 | 25 nL/min | 1 | ||
SYSMHC00023 | SYSMHC00023_MM5-HLAp | SYSMHC00023_20140305_EXQ6_MiBa_SA_MM5-HLAp-2.raw | Human | In vivo | Skin | Melanoma | Metastatic | class I | HLA-A01:01,HLA-A25:01,HLA-B08:01,HLA-B18:01 | 27869121 | native | Immunoaffinity | W6/32 | Q-Exactive HF | no-LC, Proxeon Biosystems, Thermo | no | DDA | HCD | 2-30% ACN | 90 | 25 nL/min | 2 | ||
SYSMHC00023 | SYSMHC00023_MM5-HLAp | SYSMHC00023_20140306_EXQ6_MiBa_SA_MM5-HLAp-1.raw | Human | In vivo | Skin | Melanoma | Metastatic | class I | HLA-A01:01,HLA-A25:01,HLA-B08:01,HLA-B18:01 | 27869121 | native | Immunoaffinity | W6/32 | Q-Exactive HF | no-LC, Proxeon Biosystems, Thermo | no | DDA | HCD | 2-30% ACN | 90 | 25 nL/min | 3 | ||
SYSMHC00023 | SYSMHC00023_MM5-HLAp | SYSMHC00023_20140306_EXQ6_MiBa_SA_MM5-HLAp-2.raw | Human | In vivo | Skin | Melanoma | Metastatic | class I | HLA-A01:01,HLA-A25:01,HLA-B08:01,HLA-B18:01 | 27869121 | native | Immunoaffinity | W6/32 | Q-Exactive HF | no-LC, Proxeon Biosystems, Thermo | no | DDA | HCD | 2-30% ACN | 90 | 25 nL/min | 4 |